Shereen Hamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shereen Hamed has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Hassan Reda Hassan Elsayed
Department of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
3 shared publications - Mohammed Rami Rabei
Department of Medical Physiology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
3 shared publications - Mohammad El-Nablaway
Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O.Box 71666, Riyadh, 11597, Saudi Arabia; Research Center, Deanship of Scientific Research and Post-Graduate Studies, AlMaarefa University, P.O. Box 71666, Riyadh, 11597, Saudi Arabia; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt
2 shared publications - Adel Ibrahim Alalawy
Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia
1 shared publication - Ahlam Elmasry
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
1 shared publication Ahmed Abdel-Monem Elmetwally
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
1 shared publication
Latest Publications
- 16 July 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 1) , 103797
BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASH
- 16 July 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 1) , 103797
BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASH
- Open Access
Targeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors
Long-term use of Glucocorticoids produces skeletal muscle atrophy and microvascular rarefaction. Hydrogen sulfide (H2S) has a potential role in skeletal muscle regeneration. However, the mechanisms still need to be elucidated. This is the first study to explore the effect of Sodium hydrosulfide (NaHS) H2S donor, against Dexamethasone (Dex)-induced soleus muscle atrophy and microvascular rarefaction and on muscle endothelial progenitors and M2 macrophages. Rats received either; saline, Dex (0.6 mg/Kg/day), Dex + NaHS (5 mg/Kg/day), or Dex + Aminooxyacetic acid (AOAA), a blocker of H2S (10 mg/Kg/day) for two weeks. The soleus muscle was examined for contractile properties. mRNA expression for Myostatin, Mechano-growth factor (MGF) and NADPH oxidase (NOX4), HE staining, and immunohistochemical staining for caspase-3, CD34 (Endothelial progenitor marker), vascular endothelial growth factor (VEGF), CD31 (endothelial marker), and CD163 (M2 macrophage marker) was performed. NaHS could improve the contractile properties and decrease oxidative stress, muscle atrophy, and the expression of NOX4, caspase-3, Myostatin, VEGF, and CD31 and could increase the capillary density and expression of MGF with a significant increase in expression of CD34 and CD163 as compared to Dex group. However, AOAA worsened the studied parameters. Therefore, H2S can be a promising target to attenuate muscle atrophy and microvascular rarefaction.
Open AccessTargeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors
Long-term use of Glucocorticoids produces skeletal muscle atrophy and microvascular rarefaction. Hydrogen sulfide (H2S) has a potential role in skeletal muscle regeneration. However, the mechanisms still need to be elucidated. This is the first study to explore the effect of Sodium hydrosulfide (NaHS) H2S donor, against Dexamethasone (Dex)-induced soleus muscle atrophy and microvascular rarefaction and on muscle endothelial progenitors and M2 macrophages. Rats received either; saline, Dex (0.6 mg/Kg/day), Dex + NaHS (5 mg/Kg/day), or Dex + Aminooxyacetic acid (AOAA), a blocker of H2S (10 mg/Kg/day) for two weeks. The soleus muscle was examined for contractile properties. mRNA expression for Myostatin, Mechano-growth factor (MGF) and NADPH oxidase (NOX4), HE staining, and immunohistochemical staining for caspase-3, CD34 (Endothelial progenitor marker), vascular endothelial growth factor (VEGF), CD31 (endothelial marker), and CD163 (M2 macrophage marker) was performed. NaHS could improve the contractile properties and decrease oxidative stress, muscle atrophy, and the expression of NOX4, caspase-3, Myostatin, VEGF, and CD31 and could increase the capillary density and expression of MGF with a significant increase in expression of CD34 and CD163 as compared to Dex group. However, AOAA worsened the studied parameters. Therefore, H2S can be a promising target to attenuate muscle atrophy and microvascular rarefaction.
- Open Access
Enhanced Autophagic Flux, Suppressed Apoptosis and Reduced Macrophage Infiltration by Dasatinib in Kidneys of Obese Mice
Obesity causes renal changes (ORC), characterized by defective renal autophagy, lipogenesis, enhanced macrophage infiltration and apoptosis. We hypothesize that Dasatinib, a tyrosine kinase inhibitor, may ameliorate changes associated with obesity. We the mice with either Obesogenic diet (OD) or a standard basal diet. After 12 weeks, the mice received either vehicle or Dasatinib 4 mg/kg/d for an additional four weeks. We examined serum creatinine, urea, lipid profile and renal cortical mRNA expression for lipogenesis marker SREBP1, inflammatory macrophage marker iNOS and fibrosis markers; TGFβ and PDGFA genes; immunohistochemical (IHC) staining for CD68; inflammatory macrophage marker and ASMA; fibrosis marker, LC3 and SQSTM1/P62; autophagy markers and western blotting (WB) for caspase-3; and, as an apoptosis marker, LC3II/I and SQSTM1/P62 in addition to staining for H&E, PAS, Sirius red and histopathological scoring. Dasatinib attenuated renal cortical mRNA expression for SREBP1, iNOS, PDGFA and TGFβ and IHC staining for CD68, ASMA and SQSTM1/P62 and WB for caspase-3 and SQSTM1/P62, while elevating LC3 expression. Moreover, Dasatinib ameliorated ORC; glomerulosclerosis, glomerular expansion, tubular dilatation, vacuolation and casts; inflammatory cellular infiltration; and fibrosis. Dasatinib is a promising therapy for ORC by correcting autophagy impairment, attenuating lipogenesis, apoptosis and macrophage infiltration by inducing antifibrotic activity.
Open AccessEnhanced Autophagic Flux, Suppressed Apoptosis and Reduced Macrophage Infiltration by Dasatinib in Kidneys of Obese Mice
Obesity causes renal changes (ORC), characterized by defective renal autophagy, lipogenesis, enhanced macrophage infiltration and apoptosis. We hypothesize that Dasatinib, a tyrosine kinase inhibitor, may ameliorate changes associated with obesity. We the mice with either Obesogenic diet (OD) or a standard basal diet. After 12 weeks, the mice received either vehicle or Dasatinib 4 mg/kg/d for an additional four weeks. We examined serum creatinine, urea, lipid profile and renal cortical mRNA expression for lipogenesis marker SREBP1, inflammatory macrophage marker iNOS and fibrosis markers; TGFβ and PDGFA genes; immunohistochemical (IHC) staining for CD68; inflammatory macrophage marker and ASMA; fibrosis marker, LC3 and SQSTM1/P62; autophagy markers and western blotting (WB) for caspase-3; and, as an apoptosis marker, LC3II/I and SQSTM1/P62 in addition to staining for H&E, PAS, Sirius red and histopathological scoring. Dasatinib attenuated renal cortical mRNA expression for SREBP1, iNOS, PDGFA and TGFβ and IHC staining for CD68, ASMA and SQSTM1/P62 and WB for caspase-3 and SQSTM1/P62, while elevating LC3 expression. Moreover, Dasatinib ameliorated ORC; glomerulosclerosis, glomerular expansion, tubular dilatation, vacuolation and casts; inflammatory cellular infiltration; and fibrosis. Dasatinib is a promising therapy for ORC by correcting autophagy impairment, attenuating lipogenesis, apoptosis and macrophage infiltration by inducing antifibrotic activity.
- Open Access
- 31 October 2021
- Published by Mansoura University in Mansoura Medical Journal
- Vol. 50 (3) , 129-147
Histological Study of Hyaline Articular Cartilage changes in a Rat Model of Complete Freund’s Adjuvant-Induced arthritis of the Knee Joint
Background: Arthritis is the most common joint disorder. The most significant structural change seen in arthritis is the degeneration of the articular cartilage. Numerous animal models are used to reproduce arthritis. In this paper, we assessed the ability of complete Freund's adjuvant (CFA) to induce degenerative changes of hyaline articular cartilage in rat chronic arthritis model. Methods: In this study, 42 adult male albino rats were used, divided into: control group I (18 rats) and arthritis group II (24 rats). Arthritis was induced unilaterally by a single intra-articular injection of 125 μl of CFA in the right knee joint of each rat. The samples were collected 2, 6, and 10 weeks post-injection. Hematoxylin & Eosin (H&E) stain, Masson’s trichrome stain, Safranin O (S.O) stain were used to assess articular cartilage degeneration during inflammation. Results: The articular cartilage of rats of arthritis group II showed progressive inflammatory cell infiltration in the synovial membrane. Chondrocytes showed degeneration, hypertrophy and extensive proliferation. Moreover, the matrix exhibited fibrillations, fissuring, delamination and denudation with fibrous tissue within the denuded surface. The thickness of the articular cartilage, the collagen content and the proteoglycan content showed significant decrease in rats sacrificed after 10 weeks compared to rats sacrificed after 2 weeks and 6 weeks from the onset of the experiment. Conclusions: Intra-articular injection of complete Freund’s adjuvant induces progressive degeneration of the hyaline articular cartilage of the knee joint of rats. It can be useful for studies on mechanisms and strategy of treatment of knee joint arthritis.
- 31 October 2021
- Published by Mansoura University in Mansoura Medical Journal
- Vol. 50 (3) , 129-147
Open AccessHistological Study of Hyaline Articular Cartilage changes in a Rat Model of Complete Freund’s Adjuvant-Induced arthritis of the Knee Joint
Background: Arthritis is the most common joint disorder. The most significant structural change seen in arthritis is the degeneration of the articular cartilage. Numerous animal models are used to reproduce arthritis. In this paper, we assessed the ability of complete Freund's adjuvant (CFA) to induce degenerative changes of hyaline articular cartilage in rat chronic arthritis model. Methods: In this study, 42 adult male albino rats were used, divided into: control group I (18 rats) and arthritis group II (24 rats). Arthritis was induced unilaterally by a single intra-articular injection of 125 μl of CFA in the right knee joint of each rat. The samples were collected 2, 6, and 10 weeks post-injection. Hematoxylin & Eosin (H&E) stain, Masson’s trichrome stain, Safranin O (S.O) stain were used to assess articular cartilage degeneration during inflammation. Results: The articular cartilage of rats of arthritis group II showed progressive inflammatory cell infiltration in the synovial membrane. Chondrocytes showed degeneration, hypertrophy and extensive proliferation. Moreover, the matrix exhibited fibrillations, fissuring, delamination and denudation with fibrous tissue within the denuded surface. The thickness of the articular cartilage, the collagen content and the proteoglycan content showed significant decrease in rats sacrificed after 10 weeks compared to rats sacrificed after 2 weeks and 6 weeks from the onset of the experiment. Conclusions: Intra-articular injection of complete Freund’s adjuvant induces progressive degeneration of the hyaline articular cartilage of the knee joint of rats. It can be useful for studies on mechanisms and strategy of treatment of knee joint arthritis.